SALDANAR Film Coated Tablet 40 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar film coated tablet 40 milligram

laboratorios liconsa, s.a. - valsartan - film coated tablet - 40 milligram

SALDANAR Film Coated Tablet 80 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar film coated tablet 80 milligram

laboratorios liconsa, s.a. - valsartan - film coated tablet - 80 milligram

SALDANAR Film Coated Tablet 160 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar film coated tablet 160 milligram

laboratorios liconsa, s.a. - valsartan - film coated tablet - 160 milligram

SALDANAR Film Coated Tablet 320 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar film coated tablet 320 milligram

laboratorios liconsa, s.a. - valsartan - film coated tablet - 320 milligram

SALDANAR 40 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar 40 milligram film coated tablet

laboratorios liconsa, s.a. - valsartan - film coated tablet - 40 milligram

SALDANAR 80 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar 80 milligram film coated tablet

laboratorios liconsa, s.a. - valsartan - film coated tablet - 80 milligram

SALDANAR 160 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar 160 milligram film coated tablet

laboratorios liconsa, s.a. - valsartan - film coated tablet - 160 milligram

SALDANAR 320 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

saldanar 320 milligram film coated tablet

laboratorios liconsa, s.a. - valsartan - film coated tablet - 320 milligram

Sialanar European Union - English - EMA (European Medicines Agency)

sialanar

proveca pharma limited - glycopyrronium bromide - sialorrhea - drugs for functional gastrointestinal disorders - symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.